As genetic engineering rapidly transitions from experimental labs into standard clinical care, researchers from Michigan Medicine are urging caution regarding its long-term application. While a single, permanent gene-editing treatment holds the extraordinary potential to shield individuals from heart disease, high cholesterol, and hereditary chronic conditions for decades—effectively replacing a lifetime of daily medications—the medical community faces significant hurdles. Clinical biologists warn that permanently altering the human genome introduces unpredictable, irreversible physiological risks that could take many years or even generations to fully manifest, making rigorous multi-decade safety monitoring the most critical challenge in modern life sciences.
About the Author
